VS
Venkata Subba Reddy Vempalle
About Venkata Subba Reddy Vempalle
Data last updated:
Venkata Subba Reddy Vempalle is a Whole-Time Director at Sri Krishna Pharmaceuticals Limited (since 1974), Director at Clonz Biotech Private Limited (since 2020) and Director at Isha Arogya Private Limited (since 2011), and holds 1 more current directorship. The companies operate in Pharma, Life Sciences and Healthcare. The 4 current companies with reported revenue have a combined latest revenue of ₹609 Cr; the largest is Sri Krishna Pharmaceuticals Limited at ₹608 Cr (FY 2025). Earlier, Venkata Subba Reddy Vempalle was a Director at Premier Explosives Limited (1999–2009) and Director at Kellton Securities Private Limited (1990–2009) and 6 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sri Krishna Pharmaceuticals Limited U24230TG1974PLC001790 | Whole-Time Director | 26 Sep 1974 | 1974 | ₹608 Cr (FY 2025) | Active |
 Clonz Biotech Private Limited U24231TG2009PTC065376 | Director | 09 Sep 2020 | 2009 | ₹24.4 Lakh (FY 2025) | Active |
 Isha Arogya Private Limited U85100TZ2011PTC017124 | Director | 02 Jun 2011 | 2011 | ₹2.7 Lakh (FY 2025) | Active |
 Sri Krishna Biofert Private Limited U24120TG1995PTC021782 | Director | 21 Sep 1995 | 1995 | ₹1.1 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Premier Explosives Limited L24110TG1980PLC002633 | Director | 27 May 1999 | 1980 | ₹420 Cr (FY 2025) | Active |
 Kellton Securities Private Limited U65910TG1990PTC011408 | Director | 21 Jun 1990 | 1990 | ₹1.55 Cr (FY 2025) | Active |
| Kellton Commodity And Derivatives Private Limited U67120TG1995PTC021208 | Director | 26 Jul 1995 | 1995 | Active | |
| Propart Solutions India Private Limited U72300TN2003PTC051618 | Director | 20 Oct 2003 | 2003 | ₹23.3 Lakh (FY 2016) | Strike Off |
| Sri Krishna Drugs Limited L24110TG1985PLC005315 | Managing Director | 18 Feb 1985 | 1985 | Amalgamated | |
| Sri Krishna Agri - Foods Private Limited U24110TG1993PTC016704 | Director | 08 Dec 1993 | 1993 | Strike Off | |
| Sripad Equities Private Limited U67120TG1995PTC021206 | Director | 26 Jul 1995 | 1995 | ₹2.6 Lakh (FY 2016) | Dissolved (Liquidated) |
| Ensolvia Infotech Limited U72200TG2000PLC034518 | Director | 29 May 2000 | 2000 | ₹86,287 (FY 2019) | Dissolved (Liquidated) |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Venkata Subba Reddy Vempalle
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Venkata Subba Reddy Vempalle
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Venkata Subba Reddy Vempalle
Venkata Subba Reddy Vempalle currently holds 4 directorships: Sri Krishna Pharmaceuticals Limited (Whole-Time Director, since 26 Sep 1974, revenue ₹608 Cr (FY 2025)); Clonz Biotech Private Limited (Director, since 09 Sep 2020, revenue ₹24.4 Lakh (FY 2025)); Isha Arogya Private Limited (Director, since 02 Jun 2011, revenue ₹2.7 Lakh (FY 2025)); Sri Krishna Biofert Private Limited (Director, since 21 Sep 1995, revenue ₹1.1 Lakh (FY 2025)).
Venkata Subba Reddy Vempalle was first appointed on 26 Sep 1974 as Whole-Time Director at Sri Krishna Pharmaceuticals Limited. The most recent appointment on record is 09 Sep 2020 at Clonz Biotech Private Limited.
The 4 current companies of Venkata Subba Reddy Vempalle that report revenue have a combined latest revenue of ₹609 Cr: Sri Krishna Pharmaceuticals Limited ₹608 Cr (FY 2025); Clonz Biotech Private Limited ₹24.4 Lakh (FY 2025); Isha Arogya Private Limited ₹2.7 Lakh (FY 2025); Sri Krishna Biofert Private Limited ₹1.1 Lakh (FY 2025).
Venkata Subba Reddy Vempalle held 8 earlier board appointments: Premier Explosives Limited (Director, 27 May 1999 to 30 Sep 2009); Kellton Securities Private Limited (Director, 21 Jun 1990 to 16 Sep 2009); Kellton Commodity And Derivatives Private Limited (Director, 26 Jul 1995 to 22 Jan 2010); Propart Solutions India Private Limited (Director, 20 Oct 2003 to 30 Dec 2005); Sri Krishna Drugs Limited (Managing Director, from 18 Feb 1985); and 3 more.
The current boards of Venkata Subba Reddy Vempalle's companies include Kalluru Manaswini (Sri Krishna Pharmaceuticals Limited), Kalluru Manaswini (Sri Krishna Pharmaceuticals Limited), Muri Reddy Madhusudhan (Sri Krishna Pharmaceuticals Limited), Nikhil Bihari Pandey (Sri Krishna Pharmaceuticals Limited), Nikhil Bihari Pandey (Sri Krishna Pharmaceuticals Limited), Pranesh Raj Mathur (Sri Krishna Pharmaceuticals Limited), among others.